Vistin Pharma ASA (LON:0RAM)
London
· Delayed Price · Currency is GBP · Price in NOK 22.90
-1.50 (-6.15%)
At close: Jan 15, 2025
Vistin Pharma ASA Revenue
In the year 2024, Vistin Pharma ASA had annual revenue of 429.50M NOK, down -2.01%. Vistin Pharma ASA had revenue of 113.70M in the quarter ending December 31, 2024, with 2.69% growth.
Revenue
429.50M NOK
Revenue Growth
-2.01%
P/S Ratio
n/a
Revenue / Employee
5.58M NOK
Employees
77
Market Cap
74.73M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 429.50M | -8.83M | -2.01% |
| Dec 31, 2023 | 438.33M | 133.48M | 43.78% |
| Dec 31, 2022 | 304.85M | 26.23M | 9.41% |
| Dec 31, 2021 | 278.62M | 24.72M | 9.73% |
| Dec 31, 2020 | 253.91M | 25.78M | 11.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| BP p.l.c. | 149.68B |
| British American Tobacco p.l.c. | 25.87B |